Form D · Biotechnology
Lead Therapeutics, Inc.
San Bruno, CA · CIK 0001400100
Offering snapshot reported Jun 3, 2009 · SEC filing
- Reported sold
- $3M Offering amount: $7M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 3, 2009 | Initial | $3,000,000 | No comparison | Not reported | SEC filing |
| Oct 9, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 8, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-103170
Source: Form D, filed Jun 3, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Hanabusa | Executive |
| Peter Myers | Director, Executive |
| Arthur Pappas | Director |
| Leonard Post | Director, Executive |
| Shuang Qiao | Executive |
| Alain Schreiber | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
999 Bayhill Drive, Suite 130
San Bruno, CA, 94066
San Bruno, CA, 94066